Cannabis
Evn CBD Creates and Delivers Pure, Great-Tasting CBD-Infused Products That Customers Trust
Evn CBD launched after founder Josh Krumholz sought a way to alleviate his anxiety. He tried many things until he discovered the benefits of CBD. After discovering how much CBD helped not only his anxiety but also his joint and GI issues, Krumholz made it his mission to deliver high-quality, great-tasting, CBD products that people can trust.
CBD — known formally as Cannabidiol — is one of the many compounds found in the cannabis plant. CBD is not psychoactive, meaning it does not produce a “high” or any associated mind-altering effects. In an effort to make Evn’s products as tolerable to digest as possible, they are made free from gluten, dairy, eggs and peanuts.
“The anxiety came out of nowhere, really,” explains Krumholz. It started in college, and he’s battled it for a decade since. During that time, he sought both conventional and alternative solutions including medication, Chinese herbs, acupuncture and meditation. Although some of these things have helped, CBD has become his go-to when anxiety strikes.
Evn’s flagship product is their fruit-flavored gummies, made with clean ingredients and organically sourced CBD. It contains sugar, gelatin, citric acid, organic broad-spectrum CBD, natural flavoring, natural coloring and coconut oil.
“People love them because they’re convenient to take with you to work or to your competition,” explains Krumholz. “It is satisfying to receive the positive responses from people that we have been getting. I’m happy to hear they are having the same results that I’ve been having. We even have quite a few professional athletes using our products.”
The company also offers free shipping in the United States. To learn more, visit Evn-CBD.com.
-
Cannabis2 weeks ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis7 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis7 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis6 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth